A recent analysis by Rebecca Brittain at Jagiellonian University Medical College reveals that the gut microbiomes of people in industrialized societies possess up to seven times greater capacity to recycle oestrogens compared with hunter-gatherers and traditional farmers. The study, which re-examined publicly available metagenomic sequencing data from hundreds of participants across 24 populations, focused on the abundance and diversity of genes encoding beta-glucuronidase enzymes. These enzymes remove sugar tags added by the liver to mark sex hormones for excretion, allowing the hormones to be reabsorbed into the bloodstream. This mechanism, part of what researchers call the 'oestrobolome,' was first conceptualized in a 2011 peer-reviewed paper by Plottel and Blaser in Cell Host & Microbe.

Methodology-wise, Brittain's team did not collect new samples or directly measure circulating hormone levels; instead, they quantified bacterial gene sequences from existing datasets. These included hunter-gatherers from Botswana and Nepal, rural farmers in Venezuela and Nepal, and urban residents exclusively from the United States. Key findings: industrialized microbiomes showed twice the enzyme diversity, while formula-fed infants exhibited up to three times the recycling capacity and 11 times the diversity of breastfed babies. Age, sex, and BMI showed no correlation. Limitations are significant and only partially addressed in the New Scientist coverage: the work is observational, relies on gene presence as a proxy for function, lacks direct hormone assays, and its 'industrialized' cohort is geographically narrow (US-only), reducing generalizability to Europe or Asia. It also cannot yet prove causation or rule out compensation by the body's endocrine feedback loops.

The original reporting correctly highlights potential impacts on fertility, cancer risk, and hormone-sensitive diseases but misses critical patterns and connections visible when synthesizing broader evidence. A 2019 Nature paper by Sonnenburg and colleagues documented how industrialization has caused wholesale loss of microbial diversity in the human gut, driven by low-fiber diets, antibiotics, sanitation, and C-sections. Brittain's findings invert one consequence of that loss: while overall diversity drops, specific metabolic functions like hormone recycling appear strongly amplified, likely because Western diets and environments selectively favor bacteria thriving on host-derived sugars from conjugated hormones.

This intersects powerfully with known epidemiological trends the source underplays. Multiple long-term cohort studies, including the ALSPAC study in the UK and NHANES data in the US, show girls experiencing menarche roughly three months earlier per decade since the 1970s. Rising breast cancer incidence in women under 40 has been documented in peer-reviewed registries like SEER (National Cancer Institute). While endocrine-disrupting chemicals (EDCs) such as BPA and phthalates receive deserved attention from environmental chemistry, the oestrobolome suggests an internal biological amplifier: modern microbiomes may be magnifying the effects of both endogenous hormones and synthetic xenoestrogens. A 2022 review in Endocrine Reviews on the gut-hormone axis further supports this, linking dysbiosis to conditions ranging from endometriosis to prostate issues in men via the parallel 'testobolome' pathway proposed earlier this year.

What others miss is the profound societal dimension. Declining fertility rates in high-income countries cannot be explained by economics and delayed parenthood alone; chronically elevated lifetime oestrogen exposure, seeded in infancy by formula feeding and sustained by urban living, offers a plausible biological contributor. Breastfeeding's protective effect on microbiome configuration may represent one of the earliest points of divergence between traditional and modern endocrine trajectories. Moreover, the assumption that more recycling is uniformly harmful, as critiqued by Brittain herself, deserves nuance: for perimenopausal women with declining natural oestrogen, it might offer unrecognized benefits against osteoporosis or cognitive decline. Yet population-level shifts still risk increasing hormone-driven pathologies.

Genuine analysis reveals this as a classic evolutionary mismatch. Hunter-gatherer microbiomes, shaped over millennia, maintained lower recycling rates presumably aligned with reproductive and survival needs in resource-scarce environments. Contemporary lifestyles, through the lens of environmental chemistry, endocrinology, and microbial ecology, have unintentionally engineered a new steady state of amplified hormonal signaling. The under-covered intersection demands longitudinal studies that combine metagenomics, serum hormone profiling, and health outcomes across truly global cohorts. Interventions such as targeted prebiotics, fiber restoration, or even microbiome transplants could eventually recalibrate the oestrobolome. Until then, modern living isn't just changing our external environment; it's reprogramming our internal chemistry with consequences we are only beginning to quantify.